2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum

C50H44N3OPt- — CID 153476062

IUPAC2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum
SMILES[2H]c1c([2H])c(C([2H])([2H])[2H])c([2H])c([2H])c1-c1ccnc(-c2[c-]c(-c3cccc4c3nc(-c3ccccc3O)n4-c3cc(-c4ccccc4)cc(C([2H])(C)C)c3)cc(C(C)(C)C)c2)c1.[Pt]
InChIInChI=1S/C50H44N3O.Pt/c1-32(2)37-25-38(34-13-8-7-9-14-34)30-42(29-37)53-46-17-12-16-43(48(46)52-49(53)44-15-10-11-18-47(44)54)39-26-40(28-41(27-39)50(4,5)6)45-31-36(23-24-51-45)35-21-19-33(3)20-22-35;/h7-25,27-32,54H,1-6H3;/q-1;/i3D3,19D,20D,21D,22D,32D;
InChIKeyWHKGUCWRVNHRQT-HLXZCKCJSA-N
MW906.05 g/mol
LogP12.99
Rot. Bonds8

About 2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum

2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum (PubChem CID 153476062) has the molecular formula C50H44N3OPt- and a molecular weight of 906.05 g/mol. Its IUPAC name is 2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum.

Molecular Properties

Compound Name2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum
PubChem CID153476062
Molecular FormulaC50H44N3OPt-
Molecular Weight906.05 g/mol
Exact Mass905.36
IUPAC Name2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum
SMILES[2H]c1c([2H])c(C([2H])([2H])[2H])c([2H])c([2H])c1-c1ccnc(-c2[c-]c(-c3cccc4c3nc(-c3ccccc3O)n4-c3cc(-c4ccccc4)cc(C([2H])(C)C)c3)cc(C(C)(C)C)c2)c1.[Pt]
InChIInChI=1S/C50H44N3O.Pt/c1-32(2)37-25-38(34-13-8-7-9-14-34)30-42(29-37)53-46-17-12-16-43(48(46)52-49(53)44-15-10-11-18-47(44)54)39-26-40(28-41(27-39)50(4,5)6)45-31-36(23-24-51-45)35-21-19-33(3)20-22-35;/h7-25,27-32,54H,1-6H3;/q-1;/i3D3,19D,20D,21D,22D,32D;
InChIKeyWHKGUCWRVNHRQT-HLXZCKCJSA-N
XLogP12.99
TPSA50.94 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds8
Heavy Atoms55
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500906.05
LogP ≤ 512.99
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum?
The IUPAC name of 2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum (CID 153476062) is 2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum.
What is the SMILES notation for 2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum?
The canonical SMILES for 2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum is [2H]c1c([2H])c(C([2H])([2H])[2H])c([2H])c([2H])c1-c1ccnc(-c2[c-]c(-c3cccc4c3nc(-c3ccccc3O)n4-c3cc(-c4ccccc4)cc(C([2H])(C)C)c3)cc(C(C)(C)C)c2)c1.[Pt].
What is the InChIKey of 2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum?
The InChIKey is WHKGUCWRVNHRQT-HLXZCKCJSA-N. The full InChI is InChI=1S/C50H44N3O.Pt/c1-32(2)37-25-38(34-13-8-7-9-14-34)30-42(29-37)53-46-17-12-16-43(48(46)52-49(53)44-15-10-11-18-47(44)54)39-26-40(28-41(27-39)50(4,5)6)45-31-36(23-24-51-45)35-21-19-33(3)20-22-35;/h7-25,27-32,54H,1-6H3;/q-1;/i3D3,19D,20D,21D,22D,32D;.
What are the key properties of 2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum?
2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum has a molecular weight of 906.05 g/mol, XLogP of 12.99, 8 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[3-tert-butyl-5-[4-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-[3-(2-deuteriopropan-2-yl)-5-phenylphenyl]benzimidazol-2-yl]phenol;platinum is sourced from PubChem (CID 153476062), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).